PHARMACY

Lupin receives FDA nod for generic Dacogen
Lupin has received the FDA's green light for generic Dacogen, which has a market value of about $135.9 million.
A ‘sharp’ solution for immunization season
Stericycle’s Enrico Vona writes about how mail-back sharps programs can help ease pharmacies' burden during the peak of flu immunization demand and year-round.

CVS Health, Philadelphia organizations launch mock pharmacy for students

CVS Health's partnership with several Philadelphia organizations is bringing a pre-apprenticeship and apprenticeship program to pharmacy technicians in the greater Philadelphia area.
Former senator joins Blink Health’s board

Former Sen. Kelly Ayotte will take an active role supporting Blink Health's mission of bringing transparency and affordability to the prescription drug industry.
AAM, 28 groups oppose barriers to generics, biosimilar access in USMCA

The AAM is expressing opposition, along with 28 groups, over the U.S. Mexico-Canada Agreement for its potential to keep drug prices high.
MinuteClinic, CDC partner to combat antibiotic resistance

CVS Health's MinuteClinic is joining in the Centers for Disease Control and Prevention’s yearlong Antimicrobial Resistance Challenge.
Coram CVS Specialty Home Infusion Services gets Joint Commission's Gold Seal of Approval

Coram CVS Specialty Home Infusion Services has received The Joint Commission's Gold Seal of Approval for the third time.
Xellia rolls out vancomycin

Xellia is unveiling vancomycin hydrochloride for injection, which had a market value of $338 million, according to IQVIA.
Amgen's Kyprolis' new dosing option gets FDA nod

Amgen's Kyprolis now offers patients with relapsed or refractory multiple myeloma the option of a more convenient dosing regime.
Lupin receives FDA blessing for generic Pulmicort

Lupin has received the FDA's nod for generic Pulmicort, which had a market value of about $474.5 million.